`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE NORTHERN DISTRICT OF WEST VIRGINIA
`CLARKSBURGDIVISION
`
`REGENERON PHARMACEUTICALS, INC.,
`
`Plaintiff,
`
`V.
`
`MYLAN PHARMACEUTICALSINC..,
`
`Defendant.
`
`
`
`Case No. 1:22-cv-00061-TSK
`
`JURY TRIAL DEMANDED
`
`SCHEDULING ORDER
`
`On September 28, 2022, this Court held a Scheduling Conference in the above-styled
`
`matter. Pursuant to Federal Rules of Civil Procedure 16(b) and 26(f), and the Local Rules of
`
`Civil Procedure, it is hereby ORDEREDthat the below listed dates be adopted:
`
`
`
`Regeneronidentifies 6 patents from 3 patent
`families for initial proceedings. All deadlines herein
`apply only to those patents.
`Regeneronstipulates that it will not seek injunctive
`reliefon the other 18 patents asserted in its
`
`3 daysafter this Order
`
`.
`
`November 1, 2022
`
`November3, 2022
`
`November17, 2022
`
`Complaint (ECF 1) with respect to the United States
`marketing or sales of Mylan’s current aBLA Product
`
`(BLA No.761274)
`Submission of Protective Order or Disagreements
`concerning same
`Markman: exchange ofproposed terms for
`construction
`Markman: exchangeofpreliminary constructions
`and intrinsic support
`Markman: File joint claim construction chart
`The parties may identify no more than 12 claim
`terms for construction (6 per side)
`
`November 10, 2022
`
`November 17, 2022
`
`Markman: file positions regarding word limits
`
`Samsung Bioepis Exhibit 1051
`Page 1
`Biocon Exhibit 1051 - Page 1
`
`
`
`Case 1:22-cv-00061-TSK Document 87 Filed 10/25/22 Page 2 of 2 PagelD #: 2216
`
`Markman: parties file joint opening claim
`construction briefs
`Markman: parties file joint responsive claim
`construction briefs
`
`November 29, 2022
`
`December 15, 2022
`
`December 7, 2022
`Substantial completion of document production
`January 6, 2023 (10:00 a.m.)
`Markmanhearing
`
`Deadline to amend pleadings
`December 9, 2022
`Parties serve final infringement and invalidity
`January 12, 2023
`
`contentions
`
`Close of Fact Discovery
`
`Regeneron narrowsinitial proceedings to 3 patents
`and 25 claims
`
`January 18, 2023
`7 days after Markman order or 7 days
`after close of fact discovery, whichever
`is later
`
`Opening Expert Reports on Issues for Which the
`Party Bears the Burden ofProof
`Responsive/Rebuttal Expert Reports
`Reply Expert Reports
`Motions for Summary Judgment(if any)
`
`February 2, 2023
`March 2, 2023
`March 30, 2023
`April 20, 2023
`
`
`
`wetoMotionsforSummaryJudgment(if =4.2023
`
`
`
`
`
`RepliestoResponsesfoMotionsforSummaryRepliestoResponsesfoMotionsforSummarytoResponsestoMotions forSummary(ifany) pay11.200311. 2023
`
`
`MotionsinLimineandDaubertMotions eas11,2023
`
`MotostoMotionsinLimineandDaubertpMay18.200818.2023
`
`Close of Expert Discovery
`
`April 20, 2023
`
`otions
`
`It is so ORDERED.
`
`The Clerk is directed to transmit copies of this Order to all counsel of record herein.
`
`DATED: October 25, 2022
`
`Ton $ Kl
`
`THOMASS. KLEEH, CHIEF JUDGE
`NORTHERN DISTRICT OF WEST VIRGINIA
`
`SamsungBioepis Exhibit 1051
`Page 2
`Biocon Exhibit 1051 - Page 2
`
`